Microplastics and Misinformation: What Science Really Says
November 12, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Giazo (dsc), Colazal
Synonyms :
Class :
5-Aminosalicylates
Brand Name :
Giazo (dsc), Colazal
Synonyms :
Class :
5-Aminosalicylates
Dosage Forms & Strengths
Capsule
750mg
Tablet
1.1g
3 capsules orally three times a day
Giazo (males): 3 capsules orally two times a day 8 weeks
Dosage Forms & Strengths
Capsule
750mg
3 capsules orally three times a day 8 weeks
measles, mumps, rubella, and varicella vaccine, live (Rx)
may enhance the adverse/toxic effect of varicella virus-containing vaccines
measles mumps and rubella vaccine, live
may enhance the adverse/toxic effect of varicella virus-containing vaccines
may enhance the adverse/toxic effect of varicella virus-containing vaccines
vaccinia immune globulin intravenous (Rx)
may enhance the adverse/toxic effect of varicella virus-containing vaccines
may enhance the adverse/toxic effect of varicella virus-containing vaccines
measles, mumps, rubella and varicella vaccine, live
may increase the toxic effects of varicella virus containing vaccine
may diminish the excretion rate of amantadine
may increase the risk of hypertension when combined
may increase the toxic effect of 5-aminosalicylic Acid Derivatives
balsalazide: it may increase the risk of methemoglobinemia agents
balsalazide: it may increase the risk of methemoglobinemia agents
balsalazide: it may increase the risk of methemoglobinemia agents
balsalazide: it may increase the risk of methemoglobinemia agents
balsalazide: it may increase the risk of methemoglobinemia agents
ciprofloxacin inhaled (Pending FDA approval)
may enhance the photosensitizing effect of photosensitizing agents
NSAIDs may increase the nephrotoxic effect of 5-aminosalicylic acid derivatives
NSAIDs may increase the nephrotoxic effect of 5-aminosalicylic acid derivatives
NSAIDs may increase the nephrotoxic effect of 5-aminosalicylic acid derivatives
NSAIDs may increase the nephrotoxic effect of 5-aminosalicylic acid derivatives
NSAIDs may increase the nephrotoxic effect of 5-aminosalicylic acid derivatives
may enhance the effect of myelosuppressive agents
may enhance the effect of myelosuppressive agents
may enhance the effect of myelosuppressive agents
may enhance the effect of myelosuppressive agents
may enhance the effect of myelosuppressive agents
may have an increased myelosuppressive effect when combined with myelosuppressive agents
5-Aminosalicylic Acid Derivatives: they may diminish the serum concentration of cardiac glycosides
5-Aminosalicylic Acid Derivatives: they may diminish the serum concentration of cardiac glycosides
5-Aminosalicylic Acid Derivatives: they may diminish the serum concentration of cardiac glycosides
5-Aminosalicylic Acid Derivatives: they may increase the anticoagulant effect of Vitamin K Antagonists
5-Aminosalicylic Acid Derivatives: they may increase the anticoagulant effect of Vitamin K Antagonists
5-Aminosalicylic Acid Derivatives: they may increase the anticoagulant effect of Vitamin K Antagonists
5-Aminosalicylic Acid Derivatives: they may increase the anticoagulant effect of Vitamin K Antagonists
5-Aminosalicylic Acid Derivatives: they may increase the anticoagulant effect of Vitamin K Antagonists
5-Aminosalicylic Acid Derivatives: they may increase the myelosuppressive effect of myelosuppressive agents
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
When melitracen is used together with balsalazide, this leads to increased risk or seriousness of gastrointestinal bleeding
When balsalazide is used together with andrographolide, this leads to enhanced risk or seriousness of bleeding
When cefmenoxime is used together with balsalazide, this leads to enhanced risk or seriousness of nephrotoxicity
When balsalazide is used together with proglumetacin, this leads to enhanced risk or seriousness of adverse events
When bufexamac is used together with balsalazide, this leads to a reduction in therapeutic effectiveness of balsalazide
When balsalazide is used together with benoxaprofen, this leads to enhanced risk or seriousness of adverse events
balsalazide leads to a reduction in the rate of excretion of eucalyptus oil which leads to increased level of serum
may have an increased nephrotoxic effect when combined with 5-aminosalicylic acid
balsalazide leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
When lopinavir is used together with balsalazide, this leads to enhanced risk or seriousness of nephrotoxicity
gadopentetic acid may decrease the excretion rate of balsalazide, potentially resulting in a higher serum level
balsalazide leads to a reduction in the rate of excretion of nitric oxide, which leads to an increased level of serum
balsalazide: it may decrease the excretion rate of iothalamic acid
When balsalazide is used together with nifenazone, this leads to enhanced risk or seriousness of adverse events
balsalazide: it may increase the risk or severity of CNS depression
balsalazide: it may increase the risk or severity of CNS depression
balsalazide: it may increase the risk or severity of CNS depression
balsalazide: it may increase the risk or severity of CNS depression
balsalazide: it may increase the risk or severity of CNS depression
When balsalazide is used together with difenpiramide, this leads to increased risk or seriousness of adverse events
balsalazide: it may increase the risk of CNS depression
balsalazide: it may increase the risk of CNS depression
balsalazide: it may increase the risk of CNS depression
balsalazide: it may increase the severity of hypertension with procaterol
balsalazide: it may decrease activities of antihypertensive drugs
balsalazide: it may decrease activities of antihypertensive drugs
balsalazide: it may decrease activities of antihypertensive drugs
balsalazide: it may decrease activities of antihypertensive drugs
balsalazide: it may decrease activities of antihypertensive drugs
balsalazide: it may increase the risk of gastrointestinal bleeding with risedronic acid
may have an increased nephrotoxic effect when combined with 5-aminosalicylic acid
balsalazide may decrease the excretion rate of almasilate, leading to higher serum levels
When balsalazide is used together with diazoxide, this leads to reduction in therapeutic effectiveness of diazoxide
When bacampicillin combines with balsalazide, the effect and action of balsalazide decreases.
NSAIDs may enhance the adverse/toxic effect of metformin
may increase the myelosuppressive effect
may increase the myelosuppressive effect of myelosuppressive agents
may enhance the nephrotoxic effect of 5-Aminosalicylic Acid Derivatives
may enhance the nephrotoxic effect of 5-Aminosalicylic Acid Derivatives
may enhance the nephrotoxic effect of 5-Aminosalicylic Acid Derivatives
may enhance the nephrotoxic effect of 5-Aminosalicylic Acid Derivatives
may enhance the nephrotoxic effect of 5-Aminosalicylic Acid Derivatives
may increase the nephrotoxic effect of non-steroidal anti-inflammatory drugs
may increase the myelosuppressive effect of myelosuppressive agents
may enhance the risk or severity of hypertension when combined
may enhance the risk or severity of hypertension when combined
may increase the myelosuppressive effect of myelosuppressive agents
may increase the myelosuppressive effect of myelosuppressive agents
may increase the myelosuppressive effect of myelosuppressive agents
may increase the nephrotoxic effect of nonsteroidal anti-inflammatory agents
may increase the myelosuppressive effect of thiopurine analogs
may increase the myelosuppressive effect of myelosuppressive agents
may increase the myelosuppressive effect of Myelosuppressive Agents
may increase the myelosuppressive effect of Myelosuppressive Agents
may increase the Myelosuppressive effect of Myelosuppressive Agents
may diminish the serum concentration of 5-Aminosalicylic Acid Derivatives
may diminish the serum concentration of 5-Aminosalicylic Acid Derivatives
may diminish the serum concentration of 5-Aminosalicylic Acid Derivatives
the rate of excretion of inositol may be reduced
may have an increased nephrotoxic effect when combined with 5-aminosalicylic acid
the risk of adverse effects may be increased
the risk of hypertension may be increased
the risk of hypertension may be increased
balsalazide might lead to a reduction in the rate of excretion of telavancin, potentially leading to elevated levels of serum
the hypoglycemic activity of luseogliflozin may be increased
demeclocycline may decrease the therapeutic effects of the balsalazide
doxycycline may decrease the therapeutic effects of the balsalazide
by altering the gastrointestinal absorption, the concentration of cyanocobalamin may be reduced with balsalazide
Adverse drug reactions:
Frequency Defined
>10%
Vomiting
Headache
Abdominal pain
1-10%
Headache
Vomiting
Fatigue
Cough
Pharyngitis
Insomnia
Abdominal pain
Nausea
Diarrhea
Respiratory infection
Arthralgia
Rhinitis
Cramps
Myalgia
UTI
Dyspepsia
Pregnancy warnings:
AU TGA pregnancy category: C
US FDA pregnancy category: B
Lactation:
Excreted into human milk is unknown
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: balsalazide (Rx)
Why do we use balsalazide?
balsalazide (Rx) is a 5-Aminosalicylic Acid Derivatives used to treat Ulcerative Colitis.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
